Loading...

Biovica participates at the bio-europe conference, 4-6 april in Stockholm

Biovica will attend one of the largest partnering conferences serving the global biotechnology and pharmaceutical industry. The conference attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. This years spring meeting is arranged in Stockholm at Kistamässan. “With DiviTum™ we provide researchers and pharmaceutical companies with a tool for [...]

March 18th, 2016 09:00|News|

Biovica expands – recruits senior director us business development

Biovica has strengthened the company’s presence in the  United States by adding Edward M. (Ted) Suh, Ph.D. as Senior Director, US Business Development. Ted received a B.A. degree in chemistry from Yale University, and a Ph.D. degree from Harvard University,  also in chemistry.  Prior to joining Biovica, Ted worked as a medicinal chemist at Glaxo. [...]

February 8th, 2016 09:00|Press Release|

Professor Thomas Helleday at Karolinska Institutet and Biovica in research collaboration to evaluate new promising cancer treatments

The laboratory headed by Thomas Helleday at Karolinska Institutet, (Stockholm) and Biovica (Uppsala) have entered a research collaboration to improve evaluation and development of new, promising cancer therapies. The aim of the collaboration project is to assess whether information gathered with Biovicas DiviTum™ assay has the potential to provide early evidence of efficacy regarding the [...]

January 29th, 2016 11:00|Press Release|

Biovica and the international breast cancer study group & breast international group in collaboration to improve outcome for women with breast cancer

Biovica’s DiviTum™ technology has been selected by the International Breast Cancer Study Group (IBCSG, Bern) and the Breast International Group (BIG, Brussels) to be part of a state of the art trial, studying the effects of palbociclib, a promising new cancer drug. The study, named PYTHIA, will follow women with advanced breast cancer being treated [...]

December 1st, 2015 08:45|Press Release|

Biovica and Simplicitybio, a unique collaboration to offer improved drug development

The biotech company Biovica, inventors of DiviTum™ and SimplicityBio creators of the Biomarker Optimization Software System (BOSS), have agreed to collaborate to discover and improve multi-biomarker panels for faster and better evaluation of cancers and new oncology drugs. Together the companies offer a unique solution to correlate efficacy of novel drugs with patient outcome and [...]

November 20th, 2015 08:00|Press Release|

Meet Biovica at the annual BIO-Europe conference in Munich

Biovica will attend the BIO-Europe conference on November 2-4. BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. “Biovica provides pharmaceutical companies and academia with a technology to predict and evaluate efficacy of novel [...]

October 27th, 2015 09:00|News|

Biovica invited to present at Horizon 2020 seminar arranged by Stockholm Life

Biovica is invited to speak at a breakfast seminar on October 20, 2015, organized by Stockholm Life. Biovica is one of two Swedish life science SMEs selected by the European Commission to be funded through the Horizon 2020 programme, the EU Framework Programme for Research and Innovation. Biovica will share experience from the Horizon 2020 [...]

October 19th, 2015 16:16|News|

Göran Brorson elected chairman of the Biovica board of directors at annual shareholders meeting

At the annual shareholders meeting on the 14th of October, Göran Brorsson was elected as Chairman of the Biovica board of directors. Göran was from July 2000 through January 2015, the CEO of Elos, a medical device company listed on Nasdaq OMX Stockholm. He has also held several management positions in the engineering, processing, and [...]

October 16th, 2015 08:00|Press Release|

Biovica and Pelago Bioscience offer unique solution for improved drug development

  The biotech companies Pelago Bioscience and Biovica have agreed to collaborate in providing a common platform for faster and better evaluation of new oncology candidate drugs and medicines. Together the companies will provide a unique platform, correlating efficacy of novel oncology drugs with mode of action and target interaction evaluation. This solution offers the [...]

September 7th, 2015 08:00|Press Release|

Biovica participates at the Nordic Life Science Days 2015

Biovica will participate at the Nordic Life Science Days 9-10 September, 2015. The meeting is a good opportunity for Biovica to network with partners and the life science and pharma industry. DiviTum is the most sensitive and precise test in the world to measure cell growth rate in a simple blood sample. The clinical benefit [...]

August 17th, 2015 09:00|News|